Sidar Bereketoğlu

ORCID: 0000-0003-1323-7739
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Aldose Reductase and Taurine
  • SARS-CoV-2 and COVID-19 Research
  • CRISPR and Genetic Engineering
  • Viral gastroenteritis research and epidemiology
  • Diet, Metabolism, and Disease
  • Cassava research and cyanide
  • RNA and protein synthesis mechanisms
  • Heme Oxygenase-1 and Carbon Monoxide
  • COVID-19 Clinical Research Studies
  • Epigenetics and DNA Methylation
  • Biochemical effects in animals
  • Respiratory viral infections research
  • Inflammasome and immune disorders
  • Folate and B Vitamins Research
  • Pluripotent Stem Cells Research
  • Viral Infections and Immunology Research

Ankara University
2018-2021

Ribavirin is a guanosine analog with broad-spectrum antiviral activity against RNA viruses. Based on this, we aimed to show the anti-SARS-CoV-2 of this drug molecule via in vitro, silico, and molecular techniques. showed Vero E6 cells following SARS-CoV-2 infection, whereas itself did not any toxic effect over concentration range tested. In silico analysis suggested that ribavirin has impact SARS-CoV-2, acting at different viral proteins. According detailed techniques, was shown decrease...

10.1139/cjpp-2020-0734 article EN cc-by Canadian Journal of Physiology and Pharmacology 2021-03-09

Abstract Ribavirin is a guanosine analog and has broad-spectrum antiviral activity against RNA viruses. Based on this, we aimed to show the anti-SARS-CoV-2 of this drug molecule via in vitro, silico molecular techniques. showed Vero E6 cells following SARS-CoV-2 infection. In analysis suggested that Ribarivin impact cells. According detailed techniques, was shown decrease TMPRSS2 expression both at mRNA protein level 48 hours after treatment. The suppressive effect ACE2 be dependent cell...

10.1101/2020.12.04.410092 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2020-12-05

Abstract Heme oxygenase-1 (HO-1) is a stress-induced enzyme that catalyzes the breakdown of heme into biliverdin, carbon monoxide, and iron. Targeting HO-1 to treat severe COVID-19 has been suggested by several groups, yet role in SARS-CoV-2 infection remains unclear. Based on this, we aimed investigate antiviral activity Hemin, an activator HO-1. Infectivity was decreased Vero E6 cells treated with Hemin. Hemin also TMPRSS2 ACE2 mRNA levels non-infected cells, possibly explaining observed...

10.1101/2022.05.24.493187 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2022-05-25

Amaç:

10.4274/tjps.galenos.2018.81894 article EN Turkish Journal of Pharmaceutical Sciences 2019-06-01
Coming Soon ...